Dixon Technologies shares climbed over 7% on Monday as investors cheered a 47% revenue jump in the second quarter. Although profits fell by nearly half due to accounting adjustments and margin pressures, analysts remain optimistic about the company's long-term expansion, particularly the upcoming Vivo joint venture.
Dixon Technologies (India) Ltd shares rallied more than 7% on Monday, with investors focusing on the company’s robust revenue growth during the second quarter of the 2026-27 financial year. The electronics manufacturer reported a 47% year-on-year increase in revenue, which reached ₹21,794 crore, surpassing market expectations. This topline performance highlights strong demand in the company's mobile and electronics manufacturing segments, which make up the vast majority of its business.
While revenue numbers were strong, the company’s net profit showed a significant decline, falling 48.7% to ₹343.7 crore compared to the same period last year. Investors should note that this profit drop was largely influenced by lower fair value gains on the company's stake in Aditya Infotech, rather than a decline in the core business operations. Excluding such non-operational accounting adjustments, the market sentiment appeared to prioritize the company’s continued ability to scale its manufacturing operations.
Operating performance remains a key area for investors to watch. EBITDA margins, a measure of core profitability, dropped to 2.7%, down from 3.8% in the previous year. This compression was primarily driven by two factors: rising memory costs, which are a major raw material component, and the expiration of certain production-linked incentives (PLI). These margin pressures mean that while the company is selling more, it is facing higher costs that impact the bottom line.
Looking ahead, the growth strategy remains focused on scaling production. The company is currently aiming for a smartphone production target of 33-34 million units for the full financial year. A major point of interest for analysts and investors is the upcoming joint venture with Vivo. This partnership is expected to start contributing to production and revenue figures from the fourth quarter, which could act as a catalyst for future earnings growth. Brokerages including UBS, Motilal Oswal, and Nuvama have maintained a positive long-term outlook, banking on this expansion and increased manufacturing of components to offset recent margin hurdles.
However, potential risks remain. The company has a significant amount of ₹1,110 crore in pending receivables under the government's PLI scheme, and delays in realizing these funds could pressure cash flow. Additionally, the company faces working capital requirements as it expands capacity. Investors may track the progress of the Vivo joint venture in the next quarter, as well as any management commentary regarding margin recovery and the status of government incentive receivables, to gauge the company’s financial health in the coming months.